Cofoe Medical Technology Co.,Ltd.

XSEC:301087 Stock Report

Market Cap: CN¥8.3b

Cofoe Medical TechnologyLtd Past Earnings Performance

Past criteria checks 1/6

Cofoe Medical TechnologyLtd's earnings have been declining at an average annual rate of -3%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 11.2% per year. Cofoe Medical TechnologyLtd's return on equity is 4.9%, and it has net margins of 8.3%.

Key information

-3.0%

Earnings growth rate

-11.3%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate11.2%
Return on equity4.9%
Net Margin8.3%
Next Earnings Update30 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Cofoe Medical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:301087 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242,893240970105
31 Mar 242,805221873107
31 Dec 232,854254851114
30 Sep 233,223376840127
30 Jun 233,200370821127
31 Mar 233,232386826127
01 Jan 232,977302755118
30 Sep 222,45629265795
30 Jun 222,47234361291
31 Mar 222,22934952980
01 Jan 222,27642948271
30 Sep 212,33139742664
30 Jun 212,24636743456
31 Mar 212,40841846448
31 Dec 202,37542448743
31 Dec 191,46212441116
31 Dec 181,0876630511
31 Dec 17851-2427910

Quality Earnings: 301087 has high quality earnings.

Growing Profit Margin: 301087's current net profit margins (8.3%) are lower than last year (11.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 301087's earnings have declined by 3% per year over the past 5 years.

Accelerating Growth: 301087's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 301087 had negative earnings growth (-35.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.6%).


Return on Equity

High ROE: 301087's Return on Equity (4.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies